Lycopsamine N-Oxide | CAS 95462-15-0 - Request Quote
Lycopsamine N-Oxide
| SZ CAT No: | SZ-L064002 |
| CAS No | 95462-15-0 |
| Mol.F. | C15H25NO6 |
| Mol.Wt. | 315.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Lycopsamine N-Oxide is chemically (1R,7aR)-7-[[[(2S,3S)-2,3-Dihydroxy-2-(propan-2-yl)butanoyl]oxy]methyl]-1-hydroxy-2,3,5,7a-tetrahydro-1H-pyrrolizine 4-oxide (as per EP). Lycopsamine N-Oxide is supplied with detailed characterization data compliant with regulatory guideline. Lycopsamine N-Oxide can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lycopsamine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 95462-15-0
Purchase 95462-15-0
Order 95462-15-0
Enquire 95462-15-0
price of 95462-15-0
95462-15-0 Supplier
95462-15-0 Manufacturer
95462-15-0 Exporter
buy high quality Lycopsamine N-Oxide
Purchase Lycopsamine N-Oxide
Lycopsamine N-Oxide suppliers
Lycopsamine N-Oxide manufacturers
Lycopsamine N-Oxide price
Order Lycopsamine N-Oxide
Enquire Lycopsamine N-Oxide
Lycopsamine N-Oxide cost
Lycopsamine N-Oxide Supplier
Lycopsamine N-Oxide Distributor
Lycopsamine N-Oxide for Method Validation
Lycopsamine Reference Standard
Lycopsamine N-Oxide for ANDA Filing
Lycopsamine N-Oxide for Forced Degradation Studies
Lycopsamine N-Oxide Identification Standards
Lycopsamine N-Oxide for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.